ZetrOZ Systems to Showcase sam(R) Wearable Ultrasound Device For NBA and College Athletic Trainers
As injuries sideline star players during National Basketball Association playoffs, the inventors of sustained acoustic medicine will present the FDA-cleared sam® device for soft tissue healing at the NBATA Sports Medicine Meeting in Chicago and the CATS Conference in Las Vegas.
TRUMBULL, CONNECTICUT / ACCESS Newswire / May 15, 2025 / The hamstring muscle injury that sidelined NBA star Steph Curry on May 6 is a reminder that the physical toll of playing basketball can sideline players at every level. The sam® wearable ultrasound unit from ZetrOZ Systems is clinically proven to accelerate recovery and healing of soft tissue injuries common in basketball.
ZetrOZ Systems, inventors of sustained acoustic medicine, will exhibit the sam® device this week for National Basketball Association and college athletic trainers at two upcoming conferences:
Basketball, with its blend of power, contact, explosive movement and sudden pivots, puts unique demands on athletes. Basketball players are particularly susceptible to injuries including hamstring and quadricep strains, ankle sprains, shoulder strains and patellar tendinopathy, or 'jumper's knee.' The physical demands are greater during the postseason, after the 82-game season and with the stakes of every game even higher.
At the conferences, basketball trainers, sports medicine physicians and other medical professionals will see the latest research on the sam® wearable ultrasound device and see technology demonstrations at the ZetrOZ Systems booth.
'We're excited to have the opportunity to continue to educate NBA and college trainers about how they can use sam® to help their players get ready for practices and games, and get injured players back on the court,' said George K. Lewis, CEO of ZetrOZ Systems and the inventor of sustained acoustic medicine. 'The research is conclusive: sustained acoustic medicine restores function and helps people heal more quickly, without the need for invasive surgeries or potentially addictive painkillers.'
sam® is a long duration, continuous, multi-hour, high frequency ultrasound treatment that has been proven effective in soft tissue healing in over 30 Level 1-5 clinical studies, and is the only long-duration ultrasound device cleared by the U.S. Food & Drug Administration for home use.
Sustained acoustic medicine, delivered by the sam® device, increases blood vessel diameters to boost blood flow, augmenting oxygenated hemoglobin at the site and removing cytokine enzymes and cellular waste for rapid healing and reduced pain.
sam® is widely used by athletic trainers in the NFL, NBA, NCAA, and other elite athletic conferences, and has successfully treated millions of soft-tissue injuries to date.
To learn more about the sam® ultrasound unit, please visit www.samrecover.com. For more information about ZetrOZ Systems, visit www.zetroz.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices to deliver sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of 48 patents and is the exclusive manufacturer and developer of the sam® product line, designed to treat acute and chronic musculoskeletal conditions.
Contact InformationCatherine Hoblin Media Contact
SOURCE: ZetrOZ Systems
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
World's First Needle-Free Procedure Targeting Deep Facial Muscles and Skin, EMFACE® by BTL Aesthetics Surpasses 1 Million Global Treatments, Drives Rapid Adoption in Singapore's Aesthetic Market
SINGAPORE, June 10, 2025 /PRNewswire/ -- EMFACE® the groundbreaking non-invasive natural facial lifting treatment developed by BTL Aesthetics (BTL), has surpassed 1 million treatments worldwide within the first two years of its introduction. This global milestone is a testament to EMFACE®'s position as the leading non-invasive aesthetic treatment, leveraging breakthrough technology to invent the first needle-free procedure capable of effectively providing deep facial muscle toning and skin tightening for a more lifted and youthful appearance. Launched in the United States in 2022 and introduced to Singapore in March 2023, the award- winning EMFACE® quickly gained traction among aesthetic practitioners and patients seeking effective non-invasive facial rejuvenation in major markets such as the United States, Europe, Singapore, Japan, Korea and Taiwan. According to various doctors, the demand for non-invasive aesthetic treatments in Singapore continues to rise due to reduced stigma as aesthetic treatments are increasingly viewed as a form of self-care, as reported by Channel News Asia[1]. Additionally, The Straits Times[2] has also highlighted that advancements in technology are providing more convenient solutions with minimal downtime, allowing for more accessible and efficient treatments. "In recent years, we have seen a major shift in what patients are looking for – effective treatments that deliver natural-looking results without needles, surgery, or extended recovery times. Today's consumers are busy and want options that fit seamlessly into their lifestyles, and non-invasive treatments are answering that call," said Dr. Lynn Chiam, Dermatologist at the Children & Adult Skin Hair Laser Clinic. Channel News Asia[1] has also noted that The Ministry of Health (MOH) reported an average increase of 40 new licensed providers offering aesthetic services between 2020 and 2023. As more individuals seek effective and non-invasive options to achieve their desired appearance, this surge reflects the increasing preference for non-invasive treatments like EMFACE®, with demand expected to grow even further. To cater to the growing demand for non-invasive aesthetic treatments, EMFACE® effectively targets the facial elevator muscles for a natural lift in just 20 minutes, with no pain and no downtime. Although tangible results can be seen right after the treatments, a minimum of four sessions can deliver truly optimal results. Additionally, a fully personalized treatment plan can be curated by trusted Aesthetic Providers. EMFACE® is the first device in the market to utilise High-intensity Facial Electrical Stimulation (HIFES) and Synchronized RF technologies. HIFES™ selectively tones the face-elevating muscles to restore and elevate the support of facial features while Synchronized RF heating remodels and smooths the skin by increasing the levels of collagen and elastin fibers. This allows the treatment to penetrate deep into the facial muscles, lifting every layer from muscle to skin, effectively enhancing facial contours from within – a feat previously unattainable with injectables or traditional energy-based devices. EMFACE® has also expanded its capabilities with the introduction of under-eye applicators, making EMFACE® the only treatment available that addresses the root causes of ageing around the eyes non-invasively by toning muscles and tightening skin. The periorbital area is often the first to show signs of ageing with eyebags, crow's feet, and dark circles. While traditional solutions focus primarily on the skin, the new eye applicators further enhance the treatment's effectiveness by uniquely targeting both the lower part of the orbicularis oculi muscle and delicate skin in the periorbital area. As the original muscle toning and skin lifting U.S. FDA-cleared treatment, EMFACE® has been recognized for its innovative technology and revolutionary results, having won the 2025 New Beauty Award for 'Best Non-Invasive Facial Sculptor', the 2023 Northern Ireland Cosmetic Medicine Award for 'Innovative Device of the Year', and the 2023 Cosmopolitan Holy Grail Beauty Award for 'Best Treatment Game Changer'. "BTL Aesthetics is proud of reaching this remarkable milestone which underscores the commitment we have to providing cutting-edge innovative aesthetic solutions. Achieving 1 million EMFACE® treatments globally in under two years highlights the growing consumer demand for non-invasive facial lifting solutions that are painless, require no downtime, and can seamlessly fit into their busy routines," said Mr Ricardo Manaloto, General Manager of BTL Aesthetics. "We are truly heartened by the trust that our valued partner practitioners have placed in EMFACE®. Their recognition of the role that toning facial muscles plays in facial lifting reinforces its importance as a foundational component of any effective facial lifting treatment. Mr. Manaloto added. For more information about EMFACE® and the available trusted providers in Singapore, visit BTL Aesthetics Singapore at [1] Channel News Asia – Youths, seniors embracing aesthetics boom: up/youths-seniors-embracing-aesthetics-boom-4635091 [2] The Straits Times – Social media influencers driving demand for aesthetic treatments in Singapore: About BTL Aesthetics Founded in 1993, BTL has grown to become one of the world's leading medical equipment manufacturers. With 500+ engineers and 3,000+ employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including intimate health and mental wellness. Among other brands, BTL's products include EMSCULPT NEO®, EMFACE®, EXION™, EMSELLA®, EXOMIND™ as well as their proprietary HIFEM®, HIFES™ and EXOTMS™ procedures. View original content: SOURCE BTL Singapore Sign in to access your portfolio
USA Today
an hour ago
- USA Today
Australian Alex Toohey reveals how the NBL prepared him for the 2025 NBA draft
Australian Alex Toohey reveals how the NBL prepared him for the 2025 NBA draft Alex Toohey played two years in the National Basketball League, and the Australian believes that time with the Sydney Kings helped prepare him for the 2025 NBA draft. Toohey averaged 10.5 points, 3.9 rebounds, 1.5 steals and 1.3 assists on 30.2% shooting from 3-point range in 30 appearances with the Kings. He was rewarded with the NBL Next Generation Award, given to the top player under the age of 25. The 6-foot-8 forward signed with the Kings as part of the Next Stars program, which has also helped the likes of LaMelo Ball, Josh Giddey and Alexandre Sarr, among others. He is appreciative of that time, as he prepares to transition to the NBA. "I think just being a pro early, you learn those habits," Toohey said Monday after working out with the Sacramento Kings, via Sean Cunningham of KCRA-TV. "Basketball is one part of it, but everyday life is another part of it. You have a lot of time to yourself, so just making sure you're good with your time management and efficient with your body and your mind. ... I think just being able to play against grown men and be able to compete in a high-pace league." Toohey is considered a potential first-round pick because of his offensive skill set and ability to score in various ways. He also made a jump on the defensive end of the court, thanks to his instincts and 6-foot, 10 3/4-inch wingspan. The 21-year-old competed in the combine last month, averaging 12 points, five rebounds and two steals in two scrimmage games. He also recorded a 2.90-second time in the shuttle run, tied for the 16th-fastest mark among all participants this year. Toohey has also had a known workout with the Toronto Raptors this predraft cycle. He is looking to make the most of those visits and show teams he is capable of impacting games at a high level. "I think just versatility," Toohey said of what he wants to prove to teams. "Being able to play different positions, be comfortable in different situations and be a confident basketball player across the board."
Yahoo
2 hours ago
- Yahoo
1.7 Million Cartons of Eggs Recalled for Salmonella Contamination
On June 6, the United States Food & Drug Administration (FDA) announced that August Egg Company of Hilmar, CA, is recalling 1.7 million dozen cage-free and certified organic eggs. The brown eggs, which were distributed in at least nine states, have been linked to a salmonella outbreak. According to the Centers for Disease Control & Prevention (CDC), there have been 79 reported salmonella infections so far, with 21 of those people being Name: Various brands of cage-free and organic eggs Date of Recall: June 6, 2025 Plant Code Number: P-6562 or CA5330 Distribution: Arizona, California, Illinois, Indiana, Nebraska, New Mexico, Nevada, Washington, WyomingSalmonella can cause severe gastrointestinal symptoms, such as stomach cramps, diarrhea, and fever. The symptoms of salmonella can start anywhere from six hours after eating contaminated food to six days after exposure. The recalled eggs were distributed in California and Nevada from February 3, 2025 to May 15, 2025 with sell by dates of March 4, 2025 to June 4, 2025, The eggs were sold at grocers including Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less, and Ralphs. The eggs were also distributed in Walmart stores from February 3, 2025 to May 6, 2025 with sell-by dates from March 4, 2025 to June 19, 2025. Walmarts in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois sold the recalled eggs. This recall affects numerous brands of eggs, including Simply Truth Organic, which is sold at Kroger stores, and Marketside, which is sold at Walmart. Check for a full list of brands affected by the recall. If you have one of the affected cartons of eggs in your fridge, do not eat them. Instead, the FDA recommends returning the eggs to your place of purchase for a refund. If you have questions about this recall, contact August Egg Company at 1-800-710-2554, between 9 a.m. and 5 p.m. PT. Read the original article on SIMPLYRECIPES
